Caudal brainstem processing is sufficient for behavioral, sympathetic, and parasympathetic responses driven by peripheral and hindbrain glucagon-like-peptide-1 receptor stimulation
Effect of glucagon-like peptide-1 receptor agonists on heart rate in non-diabetic individuals with overweight or obesity: a systematic review and meta-analysis
Clinical studies suggest that the medication promotes significant weight loss and is well tolerated among individuals
Once-weekly semaglutide in adults with overweight or obesity (STEP 5)
Plauch, Smith & Nieset LLC and Kirkland & Ellis LLP represent Eli Lilly
GLP-1s come in injectable form and work by suppressing feelings of hunger, reducing food noise (the constant thinking about food), stimulating the pancreas to release insulin, and slowing the stomachs emptying process so that a person will feel full for longer